Personalized Pathology & Cancer Therapy
21 – 30 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases
(
- Contribution to journal › Article
-
Mark
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition
(
- Contribution to journal › Article
-
Mark
Immune effector monocyte–neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(43). p.21704-21714(
- Contribution to journal › Article
-
Mark
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer : a comparative study of transurethral resection and cystectomy specimens
(
- Contribution to journal › Article
-
Mark
The immune microenvironment of colorectal cancer - Relationship with survival, sidedness, and pre-diagnostic anthropometry
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The leukocyte complexity and mutational landscape of periampullary adenocarcinoma. Morphology matters.
2019) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study
(
- Contribution to journal › Article
-
Mark
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
2019) In Clinical cancer research : an official journal of the American Association for Cancer Research 25(23). p.7139-7150(
- Contribution to journal › Article
- 2018
-
Mark
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article